Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Holly Bradford

Clinical Trials Administrator

Holly joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSUin August 2023 working on the ORION-4 study, a double-blind randomised placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic CVD.

Prior to this, Holly worked as a Data Manager for the Cancer Research Clinical Trials Unit at the University of Birmingham on two phase III breast cancer studies.

Holly completed her BSc in Biomedical Science from the University of Birmingham in July 2022, specialising in cancer sciences.